Results 341 to 350 of about 373,608 (350)

Mechanisms and clinical activity of an EGFR and HER2 exon 20–selective kinase inhibitor in non–small cell lung cancer

Nature Medicine, 2018
Jacqulyne Robichaux, Yasir Y Elamin, Zhi Tan   +2 more
exaly  

Oncometabolite 2-Hydroxyglutarate Is a Competitive Inhibitor of α-Ketoglutarate-Dependent Dioxygenases

Cancer Cell, 2011
Wei Xu, Hui Yang, Ping Wang
exaly  

Inhibitors of Angiogenesis

2002
Steven A. Stacker, Marc G. Achen
openaire   +1 more source

Anticancer Therapy with Angiogenesis Inhibitors

Tumori Journal, 2001
C, Ghilardi, M R, Bani, R, Giavazzi
openaire   +2 more sources

Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: American Society of Clinical Oncology Clinical Practice Guideline

Journal of Clinical Oncology, 2018
Christina Lacchetti, Michael B Atkins, Ian Chau   +2 more
exaly  

The evolving landscape of tissue‐agnostic therapies in precision oncology

Ca-A Cancer Journal for Clinicians
Vivek Subbiah, Bettina Ryll, Razelle Kurzrock   +2 more
exaly  

Angiogenesis-inhibitors/bisphosphonates

Reactions Weekly, 2019
openaire   +1 more source

Noncancer Uses for Angiogenesis Inhibitors

Journal of the National Cancer Institute, 2000
openaire   +2 more sources

Brain Angiogenesis Inhibitor

2018
openaire   +1 more source

Angiogenesis-inhibitors/pyrotinib

Reactions Weekly
openaire   +1 more source